Queen’s University Belfast
Wellcome Trust ISSF Early Stage Researcher Fellowships
Centre for Experimental Medicine
Queen’s University Belfast is one of the leading universities in the UK and Ireland, with a distinguished heritage and history. With over 24,000 students, 3,700 staff and an annual turnover of some £300m, Queen’s University Belfast plays a unique leadership role in Northern Ireland. As a member of the Russell Group of UK research-intensive universities, Queen’s University Belfast combines excellence in research and education with a student centred ethos.
The prestigious Wellcome Trust Institutional Strategic Support Fund (ISSF) provides opportunities for the most promising early-career academics wishing to undertake clinical and biomedical research.
The ISSF at Queen’s University Belfast is designed to develop two of our core research strengths, in ophthalmology and respiratory disease, both of which already have exceptional international reputations.
Queen’s University Belfast’s research strength has been built upon the successful integration of clinical and basic sciences, especially in diabetic retinopathy, age-related macular degeneration, multiple sclerosis, cystic fibrosis, acute respiratory distress syndrome and asthma. The ophthalmic and respiratory disease areas share common thematic research interests around inflammation, microvascular biology and regenerative medicine within the Centre for Experimental Medicine (CEM). This is exemplified by the GMP cell therapy facility funded by the MRC clinical research infrastructure scheme in which cell therapies will be delivered for pulmonary or eye disease in early phase clinical trials. The ophthalmic and respiratory disease translational research programmes are accommodated within the state-of-the-art Wellcome-Wolfson building which recently opened following a £32Million investment, while epidemiological and health services research are hosted by the Centre for Public Health. Other schools (e.g., Pharmacy, Engineering) have also active programmes of vision research.
Also important to this programme are the strong partnerships between Queen’s University and The Institute of Ophthalmology, UCL and Moorfields Eye Hospital and The National Heart and Lung Institute, Imperial College and Royal Brompton Hospital. These fellowships will further develop the relationships to maximise clinical impact.
We currently have a number of 2-year fellowship opportunities for candidates in the foundation years of their post-doctoral careers in either ophthalmology or respiratory disease. Candidates applying for these exciting fellowships will be early stage researchers, but with already significant experience, a strong track record relative to career stage and a clear vision of how they will transition to leading an independent research programme by the end of this fellowship.
Queen’s University has generous terms and conditions of employment underpinned by excellent benefits. We also provide attractive well-being, family friendly and other lifestyle benefits.
Further information about the Centre can be found at https://www.qub.ac.uk/research-centres/wwiem/
Informal enquires may be directed to Sinead Cahill email: email@example.com :
Anticipated interview date: Thursday 8 August 2019
Salary scale: £33,199 – £39,610 per annum (potential to progress to £43,266 per annum through sustained exceptional contribution)
Closing date: Friday 14 June 2019
For full job details and essential/desirable criteria please refer to the candidate information link on our website by clicking apply. For further information or assistance contact The Resourcing Team, People and Culture, Queen’s University Belfast, BT7 1NN. Telephone (028) 9097 3044 or email on firstname.lastname@example.org
The University is committed to equality of opportunity and to selection on merit. It therefore welcomes applications from all sections of society and particularly welcomes applications from people with a disability.
Fixed term contract posts are available for the stated period in the first instance but in particular circumstances may be renewed or made permanent subject to availability of funding.